nodes	percent_of_prediction	percent_of_DWPC	metapath
Toremifene—ESR1—Alzheimer's disease	0.547	1	CbGaD
Toremifene—CYP3A4—Rivastigmine—Alzheimer's disease	0.0765	0.432	CbGbCtD
Toremifene—CYP3A4—Donepezil—Alzheimer's disease	0.0612	0.345	CbGbCtD
Toremifene—CYP3A4—Galantamine—Alzheimer's disease	0.0394	0.223	CbGbCtD
Toremifene—Endometrial hypertrophy—Rivastigmine—Alzheimer's disease	0.0187	0.088	CcSEcCtD
Toremifene—Corneal opacity—Memantine—Alzheimer's disease	0.00527	0.0248	CcSEcCtD
Toremifene—Disorder sight—Galantamine—Alzheimer's disease	0.00411	0.0193	CcSEcCtD
Toremifene—Paresis—Rivastigmine—Alzheimer's disease	0.00369	0.0174	CcSEcCtD
Toremifene—Stiffness—Rivastigmine—Alzheimer's disease	0.00354	0.0167	CcSEcCtD
Toremifene—Disorder sight—Memantine—Alzheimer's disease	0.00289	0.0136	CcSEcCtD
Toremifene—Disorder sight—Rivastigmine—Alzheimer's disease	0.00283	0.0133	CcSEcCtD
Toremifene—Appetite absent—Rivastigmine—Alzheimer's disease	0.00271	0.0127	CcSEcCtD
Toremifene—Deep vein thrombosis—Donepezil—Alzheimer's disease	0.00249	0.0117	CcSEcCtD
Toremifene—Cyst—Donepezil—Alzheimer's disease	0.00227	0.0107	CcSEcCtD
Toremifene—Deep vein thrombosis—Memantine—Alzheimer's disease	0.00226	0.0106	CcSEcCtD
Toremifene—Embolism—Memantine—Alzheimer's disease	0.00214	0.0101	CcSEcCtD
Toremifene—Cataract—Galantamine—Alzheimer's disease	0.00205	0.00967	CcSEcCtD
Toremifene—Glaucoma—Donepezil—Alzheimer's disease	0.00201	0.00948	CcSEcCtD
Toremifene—Thrombosis—Rivastigmine—Alzheimer's disease	0.0019	0.00895	CcSEcCtD
Toremifene—Vaginal haemorrhage—Memantine—Alzheimer's disease	0.00186	0.00875	CcSEcCtD
Toremifene—Glaucoma—Memantine—Alzheimer's disease	0.00183	0.0086	CcSEcCtD
Toremifene—Vaginal haemorrhage—Rivastigmine—Alzheimer's disease	0.00182	0.00856	CcSEcCtD
Toremifene—Glaucoma—Rivastigmine—Alzheimer's disease	0.00179	0.00842	CcSEcCtD
Toremifene—Rigors—Memantine—Alzheimer's disease	0.00169	0.00794	CcSEcCtD
Toremifene—Skin discolouration—Donepezil—Alzheimer's disease	0.00168	0.0079	CcSEcCtD
Toremifene—Rigors—Rivastigmine—Alzheimer's disease	0.00165	0.00776	CcSEcCtD
Toremifene—Cataract—Donepezil—Alzheimer's disease	0.00159	0.0075	CcSEcCtD
Toremifene—Musculoskeletal stiffness—Rivastigmine—Alzheimer's disease	0.0015	0.00707	CcSEcCtD
Toremifene—Skin discolouration—Rivastigmine—Alzheimer's disease	0.00149	0.00702	CcSEcCtD
Toremifene—Arthritis—Galantamine—Alzheimer's disease	0.00146	0.00688	CcSEcCtD
Toremifene—Cardiac failure—Galantamine—Alzheimer's disease	0.00145	0.00685	CcSEcCtD
Toremifene—Lethargy—Galantamine—Alzheimer's disease	0.00145	0.00682	CcSEcCtD
Toremifene—Cataract—Memantine—Alzheimer's disease	0.00145	0.00681	CcSEcCtD
Toremifene—Cataract—Rivastigmine—Alzheimer's disease	0.00141	0.00666	CcSEcCtD
Toremifene—Coordination abnormal—Memantine—Alzheimer's disease	0.0014	0.0066	CcSEcCtD
Toremifene—Dry eye—Donepezil—Alzheimer's disease	0.0014	0.00659	CcSEcCtD
Toremifene—Pulmonary embolism—Memantine—Alzheimer's disease	0.00138	0.00648	CcSEcCtD
Toremifene—Coordination abnormal—Rivastigmine—Alzheimer's disease	0.00137	0.00645	CcSEcCtD
Toremifene—Pulmonary embolism—Rivastigmine—Alzheimer's disease	0.00135	0.00634	CcSEcCtD
Toremifene—Ataxia—Galantamine—Alzheimer's disease	0.00133	0.00628	CcSEcCtD
Toremifene—Abnormal vision—Donepezil—Alzheimer's disease	0.00132	0.00622	CcSEcCtD
Toremifene—Abnormal vision—Memantine—Alzheimer's disease	0.0012	0.00565	CcSEcCtD
Toremifene—Hot flush—Donepezil—Alzheimer's disease	0.00118	0.00554	CcSEcCtD
Toremifene—Abnormal vision—Rivastigmine—Alzheimer's disease	0.00117	0.00553	CcSEcCtD
Toremifene—Menopausal symptoms—Donepezil—Alzheimer's disease	0.00117	0.00549	CcSEcCtD
Toremifene—Thrombophlebitis—Memantine—Alzheimer's disease	0.00115	0.00543	CcSEcCtD
Toremifene—Arthritis—Donepezil—Alzheimer's disease	0.00113	0.00533	CcSEcCtD
Toremifene—Thrombophlebitis—Rivastigmine—Alzheimer's disease	0.00113	0.00531	CcSEcCtD
Toremifene—Cardiac failure—Donepezil—Alzheimer's disease	0.00113	0.00531	CcSEcCtD
Toremifene—Affect lability—Donepezil—Alzheimer's disease	0.00108	0.0051	CcSEcCtD
Toremifene—Neuropathy peripheral—Galantamine—Alzheimer's disease	0.00107	0.00505	CcSEcCtD
Toremifene—Hot flush—Memantine—Alzheimer's disease	0.00107	0.00503	CcSEcCtD
Toremifene—Menopausal symptoms—Memantine—Alzheimer's disease	0.00106	0.00498	CcSEcCtD
Toremifene—Hot flush—Rivastigmine—Alzheimer's disease	0.00104	0.00492	CcSEcCtD
Toremifene—Mood swings—Donepezil—Alzheimer's disease	0.00104	0.00491	CcSEcCtD
Toremifene—Menopausal symptoms—Rivastigmine—Alzheimer's disease	0.00104	0.00488	CcSEcCtD
Toremifene—Hepatobiliary disease—Galantamine—Alzheimer's disease	0.00103	0.00487	CcSEcCtD
Toremifene—Ataxia—Donepezil—Alzheimer's disease	0.00103	0.00487	CcSEcCtD
Toremifene—Arthritis—Memantine—Alzheimer's disease	0.00103	0.00484	CcSEcCtD
Toremifene—Cardiac failure—Memantine—Alzheimer's disease	0.00102	0.00482	CcSEcCtD
Toremifene—Lethargy—Memantine—Alzheimer's disease	0.00102	0.0048	CcSEcCtD
Toremifene—Liver function test abnormal—Donepezil—Alzheimer's disease	0.00102	0.00478	CcSEcCtD
Toremifene—Arthritis—Rivastigmine—Alzheimer's disease	0.00101	0.00473	CcSEcCtD
Toremifene—Cardiac failure—Rivastigmine—Alzheimer's disease	0.001	0.00471	CcSEcCtD
Toremifene—Diplopia—Memantine—Alzheimer's disease	0.000999	0.0047	CcSEcCtD
Toremifene—Affect lability—Memantine—Alzheimer's disease	0.000983	0.00463	CcSEcCtD
Toremifene—Diplopia—Rivastigmine—Alzheimer's disease	0.000977	0.0046	CcSEcCtD
Toremifene—Affect lability—Rivastigmine—Alzheimer's disease	0.000962	0.00453	CcSEcCtD
Toremifene—Visual impairment—Galantamine—Alzheimer's disease	0.000946	0.00446	CcSEcCtD
Toremifene—Mood swings—Memantine—Alzheimer's disease	0.000946	0.00446	CcSEcCtD
Toremifene—Ataxia—Memantine—Alzheimer's disease	0.000939	0.00442	CcSEcCtD
Toremifene—Angina pectoris—Donepezil—Alzheimer's disease	0.000926	0.00436	CcSEcCtD
Toremifene—Mood swings—Rivastigmine—Alzheimer's disease	0.000926	0.00436	CcSEcCtD
Toremifene—Liver function test abnormal—Memantine—Alzheimer's disease	0.000922	0.00434	CcSEcCtD
Toremifene—Ataxia—Rivastigmine—Alzheimer's disease	0.000919	0.00433	CcSEcCtD
Toremifene—Eye disorder—Galantamine—Alzheimer's disease	0.000918	0.00432	CcSEcCtD
Toremifene—Liver function test abnormal—Rivastigmine—Alzheimer's disease	0.000902	0.00425	CcSEcCtD
Toremifene—Angiopathy—Galantamine—Alzheimer's disease	0.000891	0.00419	CcSEcCtD
Toremifene—Breast disorder—Rivastigmine—Alzheimer's disease	0.000883	0.00416	CcSEcCtD
Toremifene—Arrhythmia—Galantamine—Alzheimer's disease	0.000877	0.00413	CcSEcCtD
Toremifene—Weight increased—Donepezil—Alzheimer's disease	0.000865	0.00407	CcSEcCtD
Toremifene—Mental disorder—Galantamine—Alzheimer's disease	0.00086	0.00405	CcSEcCtD
Toremifene—Malnutrition—Galantamine—Alzheimer's disease	0.000855	0.00402	CcSEcCtD
Toremifene—Angina pectoris—Memantine—Alzheimer's disease	0.000841	0.00396	CcSEcCtD
Toremifene—Acute coronary syndrome—Donepezil—Alzheimer's disease	0.000836	0.00393	CcSEcCtD
Toremifene—Myocardial infarction—Donepezil—Alzheimer's disease	0.000831	0.00391	CcSEcCtD
Toremifene—Back pain—Galantamine—Alzheimer's disease	0.000827	0.00389	CcSEcCtD
Toremifene—Jaundice—Donepezil—Alzheimer's disease	0.000826	0.00389	CcSEcCtD
Toremifene—Angina pectoris—Rivastigmine—Alzheimer's disease	0.000823	0.00387	CcSEcCtD
Toremifene—Sweating—Donepezil—Alzheimer's disease	0.000813	0.00383	CcSEcCtD
Toremifene—Vision blurred—Galantamine—Alzheimer's disease	0.000806	0.00379	CcSEcCtD
Toremifene—Tremor—Galantamine—Alzheimer's disease	0.000801	0.00377	CcSEcCtD
Toremifene—Weight increased—Memantine—Alzheimer's disease	0.000786	0.0037	CcSEcCtD
Toremifene—Loperamide—CALM1—Alzheimer's disease	0.000781	0.207	CrCbGaD
Toremifene—Weight increased—Rivastigmine—Alzheimer's disease	0.000768	0.00362	CcSEcCtD
Toremifene—Vertigo—Galantamine—Alzheimer's disease	0.000768	0.00362	CcSEcCtD
Toremifene—Acute coronary syndrome—Memantine—Alzheimer's disease	0.000759	0.00357	CcSEcCtD
Toremifene—Neuropathy peripheral—Memantine—Alzheimer's disease	0.000754	0.00355	CcSEcCtD
Toremifene—Myocardial infarction—Memantine—Alzheimer's disease	0.000754	0.00355	CcSEcCtD
Toremifene—Acute coronary syndrome—Rivastigmine—Alzheimer's disease	0.000742	0.0035	CcSEcCtD
Toremifene—Myocardial infarction—Rivastigmine—Alzheimer's disease	0.000738	0.00348	CcSEcCtD
Toremifene—Neuropathy peripheral—Rivastigmine—Alzheimer's disease	0.000738	0.00348	CcSEcCtD
Toremifene—Visual impairment—Donepezil—Alzheimer's disease	0.000733	0.00345	CcSEcCtD
Toremifene—Hepatobiliary disease—Memantine—Alzheimer's disease	0.000728	0.00343	CcSEcCtD
Toremifene—Chest pain—Galantamine—Alzheimer's disease	0.000728	0.00343	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.000723	0.0034	CcSEcCtD
Toremifene—Sweating—Rivastigmine—Alzheimer's disease	0.000722	0.0034	CcSEcCtD
Toremifene—Hepatobiliary disease—Rivastigmine—Alzheimer's disease	0.000712	0.00335	CcSEcCtD
Toremifene—Ospemifene—ESR1—Alzheimer's disease	0.000703	0.187	CrCbGaD
Toremifene—Phenoxybenzamine—CALM1—Alzheimer's disease	0.000687	0.182	CrCbGaD
Toremifene—Nervous system disorder—Galantamine—Alzheimer's disease	0.000684	0.00322	CcSEcCtD
Toremifene—Thrombocytopenia—Galantamine—Alzheimer's disease	0.000683	0.00322	CcSEcCtD
Toremifene—Chills—Donepezil—Alzheimer's disease	0.000683	0.00322	CcSEcCtD
Toremifene—Arrhythmia—Donepezil—Alzheimer's disease	0.00068	0.0032	CcSEcCtD
Toremifene—Skin disorder—Galantamine—Alzheimer's disease	0.000678	0.00319	CcSEcCtD
Toremifene—Hyperhidrosis—Galantamine—Alzheimer's disease	0.000674	0.00318	CcSEcCtD
Toremifene—Alopecia—Donepezil—Alzheimer's disease	0.000672	0.00317	CcSEcCtD
Toremifene—Mental disorder—Donepezil—Alzheimer's disease	0.000667	0.00314	CcSEcCtD
Toremifene—Visual impairment—Memantine—Alzheimer's disease	0.000666	0.00314	CcSEcCtD
Toremifene—Anorexia—Galantamine—Alzheimer's disease	0.000665	0.00313	CcSEcCtD
Toremifene—Malnutrition—Donepezil—Alzheimer's disease	0.000662	0.00312	CcSEcCtD
Toremifene—Visual impairment—Rivastigmine—Alzheimer's disease	0.000651	0.00307	CcSEcCtD
Toremifene—Eye disorder—Memantine—Alzheimer's disease	0.000646	0.00304	CcSEcCtD
Toremifene—Back pain—Donepezil—Alzheimer's disease	0.000641	0.00302	CcSEcCtD
Toremifene—Eye disorder—Rivastigmine—Alzheimer's disease	0.000632	0.00297	CcSEcCtD
Toremifene—Insomnia—Galantamine—Alzheimer's disease	0.000631	0.00297	CcSEcCtD
Toremifene—Angiopathy—Memantine—Alzheimer's disease	0.000627	0.00295	CcSEcCtD
Toremifene—Vision blurred—Donepezil—Alzheimer's disease	0.000624	0.00294	CcSEcCtD
Toremifene—Mediastinal disorder—Memantine—Alzheimer's disease	0.000623	0.00293	CcSEcCtD
Toremifene—Tremor—Donepezil—Alzheimer's disease	0.000621	0.00292	CcSEcCtD
Toremifene—Chills—Memantine—Alzheimer's disease	0.00062	0.00292	CcSEcCtD
Toremifene—Arrhythmia—Memantine—Alzheimer's disease	0.000617	0.00291	CcSEcCtD
Toremifene—Angiopathy—Rivastigmine—Alzheimer's disease	0.000613	0.00289	CcSEcCtD
Toremifene—Alopecia—Memantine—Alzheimer's disease	0.000611	0.00288	CcSEcCtD
Toremifene—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.000609	0.00287	CcSEcCtD
Toremifene—Chills—Rivastigmine—Alzheimer's disease	0.000606	0.00286	CcSEcCtD
Toremifene—Decreased appetite—Galantamine—Alzheimer's disease	0.000606	0.00286	CcSEcCtD
Toremifene—Mental disorder—Memantine—Alzheimer's disease	0.000605	0.00285	CcSEcCtD
Toremifene—Arrhythmia—Rivastigmine—Alzheimer's disease	0.000604	0.00284	CcSEcCtD
Toremifene—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.000602	0.00284	CcSEcCtD
Toremifene—Malnutrition—Memantine—Alzheimer's disease	0.000601	0.00283	CcSEcCtD
Toremifene—Fatigue—Galantamine—Alzheimer's disease	0.000601	0.00283	CcSEcCtD
Toremifene—Alopecia—Rivastigmine—Alzheimer's disease	0.000597	0.00281	CcSEcCtD
Toremifene—Constipation—Galantamine—Alzheimer's disease	0.000597	0.00281	CcSEcCtD
Toremifene—Vertigo—Donepezil—Alzheimer's disease	0.000595	0.0028	CcSEcCtD
Toremifene—Mental disorder—Rivastigmine—Alzheimer's disease	0.000592	0.00279	CcSEcCtD
Toremifene—Malnutrition—Rivastigmine—Alzheimer's disease	0.000588	0.00277	CcSEcCtD
Toremifene—Back pain—Memantine—Alzheimer's disease	0.000582	0.00274	CcSEcCtD
Toremifene—Back pain—Rivastigmine—Alzheimer's disease	0.000569	0.00268	CcSEcCtD
Toremifene—Vision blurred—Memantine—Alzheimer's disease	0.000567	0.00267	CcSEcCtD
Toremifene—Chest pain—Donepezil—Alzheimer's disease	0.000564	0.00266	CcSEcCtD
Toremifene—Tremor—Memantine—Alzheimer's disease	0.000563	0.00265	CcSEcCtD
Toremifene—Vision blurred—Rivastigmine—Alzheimer's disease	0.000555	0.00261	CcSEcCtD
Toremifene—Tremor—Rivastigmine—Alzheimer's disease	0.000551	0.0026	CcSEcCtD
Toremifene—Oedema—Donepezil—Alzheimer's disease	0.000541	0.00255	CcSEcCtD
Toremifene—Vertigo—Memantine—Alzheimer's disease	0.00054	0.00254	CcSEcCtD
Toremifene—Leukopenia—Memantine—Alzheimer's disease	0.000538	0.00254	CcSEcCtD
Toremifene—Nervous system disorder—Donepezil—Alzheimer's disease	0.00053	0.0025	CcSEcCtD
Toremifene—Thrombocytopenia—Donepezil—Alzheimer's disease	0.000529	0.00249	CcSEcCtD
Toremifene—Vertigo—Rivastigmine—Alzheimer's disease	0.000529	0.00249	CcSEcCtD
Toremifene—Hyperhidrosis—Donepezil—Alzheimer's disease	0.000523	0.00246	CcSEcCtD
Toremifene—Anorexia—Donepezil—Alzheimer's disease	0.000515	0.00243	CcSEcCtD
Toremifene—Chest pain—Memantine—Alzheimer's disease	0.000512	0.00241	CcSEcCtD
Toremifene—Chest pain—Rivastigmine—Alzheimer's disease	0.000501	0.00236	CcSEcCtD
Toremifene—Asthenia—Galantamine—Alzheimer's disease	0.0005	0.00236	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.000497	0.00234	CcSEcCtD
Toremifene—Clomifene—ESR1—Alzheimer's disease	0.000495	0.131	CrCbGaD
Toremifene—Oedema—Memantine—Alzheimer's disease	0.000491	0.00231	CcSEcCtD
Toremifene—Insomnia—Donepezil—Alzheimer's disease	0.000489	0.0023	CcSEcCtD
Toremifene—Dyspnoea—Donepezil—Alzheimer's disease	0.000482	0.00227	CcSEcCtD
Toremifene—Nervous system disorder—Memantine—Alzheimer's disease	0.000481	0.00227	CcSEcCtD
Toremifene—Thrombocytopenia—Memantine—Alzheimer's disease	0.000481	0.00226	CcSEcCtD
Toremifene—Oedema—Rivastigmine—Alzheimer's disease	0.00048	0.00226	CcSEcCtD
Toremifene—Skin disorder—Memantine—Alzheimer's disease	0.000477	0.00225	CcSEcCtD
Toremifene—Hyperhidrosis—Memantine—Alzheimer's disease	0.000475	0.00223	CcSEcCtD
Toremifene—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.000471	0.00222	CcSEcCtD
Toremifene—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.00047	0.00221	CcSEcCtD
Toremifene—Decreased appetite—Donepezil—Alzheimer's disease	0.00047	0.00221	CcSEcCtD
Toremifene—Anorexia—Memantine—Alzheimer's disease	0.000468	0.0022	CcSEcCtD
Toremifene—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.000467	0.0022	CcSEcCtD
Toremifene—Skin disorder—Rivastigmine—Alzheimer's disease	0.000466	0.0022	CcSEcCtD
Toremifene—Fatigue—Donepezil—Alzheimer's disease	0.000466	0.00219	CcSEcCtD
Toremifene—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.000464	0.00219	CcSEcCtD
Toremifene—Pain—Donepezil—Alzheimer's disease	0.000462	0.00218	CcSEcCtD
Toremifene—Constipation—Donepezil—Alzheimer's disease	0.000462	0.00218	CcSEcCtD
Toremifene—Dizziness—Galantamine—Alzheimer's disease	0.000461	0.00217	CcSEcCtD
Toremifene—Anorexia—Rivastigmine—Alzheimer's disease	0.000458	0.00216	CcSEcCtD
Toremifene—Insomnia—Memantine—Alzheimer's disease	0.000444	0.00209	CcSEcCtD
Toremifene—Vomiting—Galantamine—Alzheimer's disease	0.000444	0.00209	CcSEcCtD
Toremifene—Rash—Galantamine—Alzheimer's disease	0.00044	0.00207	CcSEcCtD
Toremifene—Dermatitis—Galantamine—Alzheimer's disease	0.000439	0.00207	CcSEcCtD
Toremifene—Dyspnoea—Memantine—Alzheimer's disease	0.000438	0.00206	CcSEcCtD
Toremifene—Headache—Galantamine—Alzheimer's disease	0.000437	0.00206	CcSEcCtD
Toremifene—Insomnia—Rivastigmine—Alzheimer's disease	0.000434	0.00205	CcSEcCtD
Toremifene—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000428	0.00202	CcSEcCtD
Toremifene—Decreased appetite—Memantine—Alzheimer's disease	0.000427	0.00201	CcSEcCtD
Toremifene—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.000424	0.002	CcSEcCtD
Toremifene—Fatigue—Memantine—Alzheimer's disease	0.000423	0.00199	CcSEcCtD
Toremifene—Pain—Memantine—Alzheimer's disease	0.00042	0.00198	CcSEcCtD
Toremifene—Constipation—Memantine—Alzheimer's disease	0.00042	0.00198	CcSEcCtD
Toremifene—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000417	0.00197	CcSEcCtD
Toremifene—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.000415	0.00195	CcSEcCtD
Toremifene—Nausea—Galantamine—Alzheimer's disease	0.000414	0.00195	CcSEcCtD
Toremifene—Fatigue—Rivastigmine—Alzheimer's disease	0.000414	0.00195	CcSEcCtD
Toremifene—Pain—Rivastigmine—Alzheimer's disease	0.000411	0.00193	CcSEcCtD
Toremifene—Constipation—Rivastigmine—Alzheimer's disease	0.000411	0.00193	CcSEcCtD
Toremifene—Asthenia—Donepezil—Alzheimer's disease	0.000388	0.00183	CcSEcCtD
Toremifene—Pruritus—Donepezil—Alzheimer's disease	0.000382	0.0018	CcSEcCtD
Toremifene—Dizziness—Donepezil—Alzheimer's disease	0.000357	0.00168	CcSEcCtD
Toremifene—Asthenia—Memantine—Alzheimer's disease	0.000352	0.00166	CcSEcCtD
Toremifene—Pruritus—Memantine—Alzheimer's disease	0.000347	0.00164	CcSEcCtD
Toremifene—Asthenia—Rivastigmine—Alzheimer's disease	0.000345	0.00162	CcSEcCtD
Toremifene—Vomiting—Donepezil—Alzheimer's disease	0.000344	0.00162	CcSEcCtD
Toremifene—Rash—Donepezil—Alzheimer's disease	0.000341	0.00161	CcSEcCtD
Toremifene—Dermatitis—Donepezil—Alzheimer's disease	0.000341	0.0016	CcSEcCtD
Toremifene—Pruritus—Rivastigmine—Alzheimer's disease	0.00034	0.0016	CcSEcCtD
Toremifene—Headache—Donepezil—Alzheimer's disease	0.000339	0.00159	CcSEcCtD
Toremifene—Dizziness—Memantine—Alzheimer's disease	0.000325	0.00153	CcSEcCtD
Toremifene—Nausea—Donepezil—Alzheimer's disease	0.000321	0.00151	CcSEcCtD
Toremifene—Dizziness—Rivastigmine—Alzheimer's disease	0.000318	0.0015	CcSEcCtD
Toremifene—Vomiting—Memantine—Alzheimer's disease	0.000312	0.00147	CcSEcCtD
Toremifene—Rash—Memantine—Alzheimer's disease	0.000309	0.00146	CcSEcCtD
Toremifene—Dermatitis—Memantine—Alzheimer's disease	0.000309	0.00146	CcSEcCtD
Toremifene—Headache—Memantine—Alzheimer's disease	0.000308	0.00145	CcSEcCtD
Toremifene—Vomiting—Rivastigmine—Alzheimer's disease	0.000305	0.00144	CcSEcCtD
Toremifene—Rash—Rivastigmine—Alzheimer's disease	0.000303	0.00143	CcSEcCtD
Toremifene—Dermatitis—Rivastigmine—Alzheimer's disease	0.000302	0.00142	CcSEcCtD
Toremifene—Headache—Rivastigmine—Alzheimer's disease	0.000301	0.00142	CcSEcCtD
Toremifene—Nausea—Memantine—Alzheimer's disease	0.000292	0.00137	CcSEcCtD
Toremifene—Nausea—Rivastigmine—Alzheimer's disease	0.000285	0.00134	CcSEcCtD
Toremifene—Tamoxifen—ESR1—Alzheimer's disease	0.000229	0.0608	CrCbGaD
Toremifene—Diphenhydramine—PTGS1—Alzheimer's disease	0.000205	0.0545	CrCbGaD
Toremifene—Dextropropoxyphene—CYP2D6—Alzheimer's disease	0.000199	0.0528	CrCbGaD
Toremifene—Loperamide—CYP2D6—Alzheimer's disease	0.00019	0.0504	CrCbGaD
Toremifene—Diphenhydramine—CYP2D6—Alzheimer's disease	0.00014	0.0371	CrCbGaD
Toremifene—Tamoxifen—CYP2D6—Alzheimer's disease	0.000136	0.0362	CrCbGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—Alzheimer's disease	4.76e-05	0.00079	CbGpPWpGaD
Toremifene—CYP3A4—Biological oxidations—CYP2D6—Alzheimer's disease	4.72e-05	0.000784	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—CA4—Alzheimer's disease	4.71e-05	0.000783	CbGpPWpGaD
Toremifene—CYP3A4—Metapathway biotransformation—CYP2D6—Alzheimer's disease	4.65e-05	0.000773	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—Alzheimer's disease	4.63e-05	0.000769	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor—TNF—Alzheimer's disease	4.63e-05	0.000769	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	4.61e-05	0.000765	CbGpPWpGaD
Toremifene—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—Alzheimer's disease	4.59e-05	0.000763	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—MAPK8—Alzheimer's disease	4.44e-05	0.000737	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—GAPDHS—Alzheimer's disease	4.43e-05	0.000736	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—DHCR24—Alzheimer's disease	4.43e-05	0.000735	CbGpPWpGaD
Toremifene—ABCB1—Allograft Rejection—VEGFA—Alzheimer's disease	4.39e-05	0.00073	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PYY—Alzheimer's disease	4.24e-05	0.000704	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—ATP5A1—Alzheimer's disease	4.2e-05	0.000698	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—Alzheimer's disease	4.1e-05	0.000681	CbGpPWpGaD
Toremifene—ABCB1—Allograft Rejection—TGFB1—Alzheimer's disease	4.03e-05	0.00067	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PLD3—Alzheimer's disease	4.01e-05	0.000665	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	4.01e-05	0.000665	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	3.96e-05	0.000658	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—HSD17B10—Alzheimer's disease	3.84e-05	0.000638	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—Alzheimer's disease	3.83e-05	0.000637	CbGpPWpGaD
Toremifene—ABCB1—Allograft Rejection—TNF—Alzheimer's disease	3.77e-05	0.000625	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—CA4—Alzheimer's disease	3.76e-05	0.000625	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—TGFB1—Alzheimer's disease	3.76e-05	0.000625	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	3.75e-05	0.000624	CbGpPWpGaD
Toremifene—ESR1—Integrated Breast Cancer Pathway—TP53—Alzheimer's disease	3.74e-05	0.000621	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—CYP46A1—Alzheimer's disease	3.7e-05	0.000614	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CDK5—Alzheimer's disease	3.68e-05	0.00061	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—ND1—Alzheimer's disease	3.57e-05	0.000593	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—EIF2S1—Alzheimer's disease	3.55e-05	0.00059	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—GAPDHS—Alzheimer's disease	3.54e-05	0.000588	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—HTR6—Alzheimer's disease	3.54e-05	0.000588	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—DHCR24—Alzheimer's disease	3.53e-05	0.000587	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—TNF—Alzheimer's disease	3.51e-05	0.000583	CbGpPWpGaD
Toremifene—ABCB1—Transmembrane transport of small molecules—CP—Alzheimer's disease	3.5e-05	0.000581	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	3.49e-05	0.00058	CbGpPWpGaD
Toremifene—ESR1—Generic Transcription Pathway—NOTCH1—Alzheimer's disease	3.48e-05	0.000578	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—CREB1—Alzheimer's disease	3.45e-05	0.000573	CbGpPWpGaD
Toremifene—ESR1—Signaling by ERBB4—IL6—Alzheimer's disease	3.4e-05	0.000565	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—ATP5A1—Alzheimer's disease	3.35e-05	0.000557	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—Alzheimer's disease	3.32e-05	0.000551	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	3.3e-05	0.000547	CbGpPWpGaD
Toremifene—ESR1—Generic Transcription Pathway—PPARG—Alzheimer's disease	3.28e-05	0.000546	CbGpPWpGaD
Toremifene—ABCB1—HIF-1-alpha transcription factor network—AKT1—Alzheimer's disease	3.24e-05	0.000538	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PSENEN—Alzheimer's disease	3.21e-05	0.000534	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PLD3—Alzheimer's disease	3.2e-05	0.000532	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	3.19e-05	0.00053	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—APH1A—Alzheimer's disease	3.17e-05	0.000526	CbGpPWpGaD
Toremifene—ESR1—Integrated Breast Cancer Pathway—AKT1—Alzheimer's disease	3.16e-05	0.000524	CbGpPWpGaD
Toremifene—ESR1—Signaling by ERBB4—AKT1—Alzheimer's disease	3.14e-05	0.000521	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—TP53—Alzheimer's disease	3.1e-05	0.000514	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—NCSTN—Alzheimer's disease	3.08e-05	0.000512	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—HSD17B10—Alzheimer's disease	3.07e-05	0.00051	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—LRP1—Alzheimer's disease	3.01e-05	0.0005	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—CA4—Alzheimer's disease	3e-05	0.000499	CbGpPWpGaD
Toremifene—ABCB1—Transmembrane transport of small molecules—TF—Alzheimer's disease	2.97e-05	0.000494	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—CYP46A1—Alzheimer's disease	2.95e-05	0.000491	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—GAL—Alzheimer's disease	2.94e-05	0.000488	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—GFAP—Alzheimer's disease	2.94e-05	0.000488	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	2.94e-05	0.000488	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—Alzheimer's disease	2.9e-05	0.000481	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—ND1—Alzheimer's disease	2.85e-05	0.000474	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—GAPDHS—Alzheimer's disease	2.83e-05	0.000469	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Alzheimer's disease	2.75e-05	0.000457	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	2.75e-05	0.000457	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—DHCR24—Alzheimer's disease	2.73e-05	0.000453	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—ATP5A1—Alzheimer's disease	2.68e-05	0.000445	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—Alzheimer's disease	2.61e-05	0.000434	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—A2M—Alzheimer's disease	2.59e-05	0.00043	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PLD3—Alzheimer's disease	2.56e-05	0.000424	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	2.55e-05	0.000424	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—Alzheimer's disease	2.55e-05	0.000424	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	2.53e-05	0.000419	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PSEN2—Alzheimer's disease	2.51e-05	0.000416	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	2.51e-05	0.000416	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—HSD17B10—Alzheimer's disease	2.45e-05	0.000407	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	2.39e-05	0.000398	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—CYP46A1—Alzheimer's disease	2.36e-05	0.000392	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—Alzheimer's disease	2.35e-05	0.00039	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—CA4—Alzheimer's disease	2.32e-05	0.000385	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—NPY—Alzheimer's disease	2.31e-05	0.000383	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—TPI1—Alzheimer's disease	2.3e-05	0.000382	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—CHAT—Alzheimer's disease	2.3e-05	0.000382	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—IAPP—Alzheimer's disease	2.29e-05	0.000381	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—ND1—Alzheimer's disease	2.28e-05	0.000378	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CRH—Alzheimer's disease	2.23e-05	0.00037	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	2.23e-05	0.00037	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—MAOB—Alzheimer's disease	2.21e-05	0.000366	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—GAPDHS—Alzheimer's disease	2.18e-05	0.000362	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—Alzheimer's disease	2.17e-05	0.00036	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—GAPDH—Alzheimer's disease	2.12e-05	0.000353	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—NPS—Alzheimer's disease	2.11e-05	0.000351	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PPP3CA—Alzheimer's disease	2.1e-05	0.000349	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	2.1e-05	0.000349	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	2.08e-05	0.000346	CbGpPWpGaD
Toremifene—ABCB1—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	2.08e-05	0.000345	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PTK2B—Alzheimer's disease	2.07e-05	0.000344	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—ATP5A1—Alzheimer's disease	2.07e-05	0.000343	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—A2M—Alzheimer's disease	2.05e-05	0.000341	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	2.04e-05	0.000338	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—GAB2—Alzheimer's disease	2.01e-05	0.000334	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—NTRK2—Alzheimer's disease	2.01e-05	0.000334	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—SST—Alzheimer's disease	2.01e-05	0.000334	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—GSK3A—Alzheimer's disease	2e-05	0.000332	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—Alzheimer's disease	1.99e-05	0.00033	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PLD3—Alzheimer's disease	1.97e-05	0.000327	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—APP—Alzheimer's disease	1.96e-05	0.000326	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—HSD17B10—Alzheimer's disease	1.89e-05	0.000314	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Alzheimer's disease	1.86e-05	0.000309	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PLCB1—Alzheimer's disease	1.85e-05	0.000308	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—TPI1—Alzheimer's disease	1.84e-05	0.000305	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—CHAT—Alzheimer's disease	1.84e-05	0.000305	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	1.83e-05	0.000304	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—CYP46A1—Alzheimer's disease	1.82e-05	0.000302	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—ACHE—Alzheimer's disease	1.78e-05	0.000296	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—INPP5D—Alzheimer's disease	1.76e-05	0.000293	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—MAOB—Alzheimer's disease	1.76e-05	0.000293	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—ND1—Alzheimer's disease	1.76e-05	0.000292	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	1.75e-05	0.000291	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—NGFR—Alzheimer's disease	1.73e-05	0.000287	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—GAPDH—Alzheimer's disease	1.7e-05	0.000282	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—ADAM10—Alzheimer's disease	1.69e-05	0.00028	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—NOTCH1—Alzheimer's disease	1.68e-05	0.000278	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—ENO1—Alzheimer's disease	1.67e-05	0.000278	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PTGS1—Alzheimer's disease	1.67e-05	0.000278	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—CYP2D6—Alzheimer's disease	1.64e-05	0.000272	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—A2M—Alzheimer's disease	1.64e-05	0.000272	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—Alzheimer's disease	1.64e-05	0.000272	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	1.6e-05	0.000265	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—S100B—Alzheimer's disease	1.6e-05	0.000265	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—PPARG—Alzheimer's disease	1.58e-05	0.000263	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—BCHE—Alzheimer's disease	1.55e-05	0.000258	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—IGF2—Alzheimer's disease	1.52e-05	0.000252	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—IGF1R—Alzheimer's disease	1.47e-05	0.000244	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—TPI1—Alzheimer's disease	1.47e-05	0.000244	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—CHAT—Alzheimer's disease	1.47e-05	0.000244	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PLCB1—Alzheimer's disease	1.47e-05	0.000244	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	1.44e-05	0.000239	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—ACHE—Alzheimer's disease	1.43e-05	0.000237	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—ABCA1—Alzheimer's disease	1.42e-05	0.000236	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—INPP5D—Alzheimer's disease	1.41e-05	0.000234	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—LPL—Alzheimer's disease	1.41e-05	0.000234	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—MAOB—Alzheimer's disease	1.41e-05	0.000234	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—MEF2C—Alzheimer's disease	1.4e-05	0.000232	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—Alzheimer's disease	1.38e-05	0.00023	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PRKCG—Alzheimer's disease	1.37e-05	0.000227	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—GAPDH—Alzheimer's disease	1.35e-05	0.000225	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	1.34e-05	0.000222	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PTGS1—Alzheimer's disease	1.34e-05	0.000222	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—ENO1—Alzheimer's disease	1.34e-05	0.000222	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—NGF—Alzheimer's disease	1.33e-05	0.000222	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	1.33e-05	0.00022	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—CYP2D6—Alzheimer's disease	1.31e-05	0.000218	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—A2M—Alzheimer's disease	1.31e-05	0.000217	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CCR5—Alzheimer's disease	1.3e-05	0.000216	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—HTR2A—Alzheimer's disease	1.27e-05	0.000211	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—BCHE—Alzheimer's disease	1.24e-05	0.000206	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PPARGC1A—Alzheimer's disease	1.23e-05	0.000204	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—HMOX1—Alzheimer's disease	1.22e-05	0.000203	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CALM1—Alzheimer's disease	1.18e-05	0.000197	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—APOE—Alzheimer's disease	1.18e-05	0.000196	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—LEP—Alzheimer's disease	1.18e-05	0.000196	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PLCB1—Alzheimer's disease	1.17e-05	0.000195	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CAV1—Alzheimer's disease	1.17e-05	0.000194	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	1.17e-05	0.000194	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—ACHE—Alzheimer's disease	1.14e-05	0.000189	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—ABCA1—Alzheimer's disease	1.14e-05	0.000189	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—TPI1—Alzheimer's disease	1.13e-05	0.000188	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—CHAT—Alzheimer's disease	1.13e-05	0.000188	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—INPP5D—Alzheimer's disease	1.12e-05	0.000187	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—LPL—Alzheimer's disease	1.12e-05	0.000185	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—F2—Alzheimer's disease	1.11e-05	0.000185	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—NOTCH1—Alzheimer's disease	1.09e-05	0.000181	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—MAOB—Alzheimer's disease	1.09e-05	0.00018	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PTGS1—Alzheimer's disease	1.07e-05	0.000177	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—ENO1—Alzheimer's disease	1.07e-05	0.000177	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—CYP2D6—Alzheimer's disease	1.05e-05	0.000174	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	1.05e-05	0.000174	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—GSK3B—Alzheimer's disease	1.02e-05	0.00017	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CREB1—Alzheimer's disease	1.01e-05	0.000168	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—A2M—Alzheimer's disease	1.01e-05	0.000168	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—INS—Alzheimer's disease	1.01e-05	0.000167	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—MTHFR—Alzheimer's disease	1e-05	0.000167	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CCL2—Alzheimer's disease	9.92e-06	0.000165	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—BCHE—Alzheimer's disease	9.91e-06	0.000165	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PPARGC1A—Alzheimer's disease	9.79e-06	0.000163	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—IGF1—Alzheimer's disease	9.76e-06	0.000162	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—HMOX1—Alzheimer's disease	9.74e-06	0.000162	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—CALM1—Alzheimer's disease	9.39e-06	0.000156	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PLCB1—Alzheimer's disease	9.35e-06	0.000155	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—APOE—Alzheimer's disease	9.35e-06	0.000155	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—CAV1—Alzheimer's disease	9.27e-06	0.000154	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	9.17e-06	0.000152	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—ABCA1—Alzheimer's disease	9.07e-06	0.000151	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—LPL—Alzheimer's disease	8.91e-06	0.000148	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—NOS3—Alzheimer's disease	8.84e-06	0.000147	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—ACHE—Alzheimer's disease	8.78e-06	0.000146	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	8.68e-06	0.000144	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	8.23e-06	0.000137	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—ENO1—Alzheimer's disease	8.23e-06	0.000137	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PPARG—Alzheimer's disease	8.15e-06	0.000135	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	8.07e-06	0.000134	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—MTHFR—Alzheimer's disease	8.02e-06	0.000133	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—INS—Alzheimer's disease	7.99e-06	0.000133	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PPARGC1A—Alzheimer's disease	7.81e-06	0.00013	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—HMOX1—Alzheimer's disease	7.78e-06	0.000129	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—BCHE—Alzheimer's disease	7.65e-06	0.000127	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CASP3—Alzheimer's disease	7.51e-06	0.000125	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—CALM1—Alzheimer's disease	7.5e-06	0.000124	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—APOE—Alzheimer's disease	7.47e-06	0.000124	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—CAV1—Alzheimer's disease	7.4e-06	0.000123	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	7.22e-06	0.00012	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—LPL—Alzheimer's disease	7.11e-06	0.000118	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—NOS3—Alzheimer's disease	7.01e-06	0.000116	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	7e-06	0.000116	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—MAPK8—Alzheimer's disease	6.9e-06	0.000115	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PPARG—Alzheimer's disease	6.51e-06	0.000108	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PTGS2—Alzheimer's disease	6.41e-06	0.000106	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—MTHFR—Alzheimer's disease	6.41e-06	0.000106	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—INS—Alzheimer's disease	6.38e-06	0.000106	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—VEGFA—Alzheimer's disease	6.37e-06	0.000106	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—AKT1—Alzheimer's disease	6.25e-06	0.000104	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	6.03e-06	0.0001	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	6e-06	9.97e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—CALM1—Alzheimer's disease	5.98e-06	9.94e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—APOE—Alzheimer's disease	5.96e-06	9.9e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—CAV1—Alzheimer's disease	5.91e-06	9.81e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—TGFB1—Alzheimer's disease	5.85e-06	9.71e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—NOS3—Alzheimer's disease	5.6e-06	9.29e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—LPL—Alzheimer's disease	5.49e-06	9.12e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PPARG—Alzheimer's disease	5.19e-06	8.63e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PTGS2—Alzheimer's disease	5.12e-06	8.5e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—INS—Alzheimer's disease	5.09e-06	8.46e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	4.94e-06	8.21e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—TP53—Alzheimer's disease	4.81e-06	8e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—CALM1—Alzheimer's disease	4.62e-06	7.67e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—APOE—Alzheimer's disease	4.6e-06	7.64e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—CAV1—Alzheimer's disease	4.56e-06	7.57e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—NOS3—Alzheimer's disease	4.47e-06	7.42e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—IL6—Alzheimer's disease	4.41e-06	7.32e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PTGS2—Alzheimer's disease	4.09e-06	6.79e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—AKT1—Alzheimer's disease	4.07e-06	6.75e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PPARG—Alzheimer's disease	4.01e-06	6.66e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—INS—Alzheimer's disease	3.93e-06	6.53e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—NOS3—Alzheimer's disease	3.45e-06	5.73e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—AKT1—Alzheimer's disease	3.22e-06	5.35e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	3.15e-06	5.24e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—AKT1—Alzheimer's disease	2.57e-06	4.27e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—AKT1—Alzheimer's disease	2.05e-06	3.41e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—AKT1—Alzheimer's disease	1.58e-06	2.63e-05	CbGpPWpGaD
